Single-use technologies provide a barrier between operators and drug products, allowing for sterility and personnel safety in manufacturing.
Ben Wylie
Advertisement
Ben Wylie is head of Product Management and Marketing at ChargePoint Technologies.
Articles by Ben Wylie
Through the adoption of single-use technology, drug manufacturers have been able to adapt to the challenges posed by the COVID-19 pandemic.
Advertisement
Latest Updated Articles
The Evolving Aseptic Processing LandscapeAugust 1st 2021
De-Risking Sterile Pharma Manufacture with SUTsNovember 15th 2023
Advertisement
Advertisement
Trending on BioPharm International
1
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
2
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
3
BioNTech, BMS to Pair Pumitamig With Trodelvy in Phase 3 First-Line TNBC Trial
4
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
5